Section
Trials explained
How clinical trials are designed, counted and reported, and what separates a settled result from an early one.
Briefings
Trials explained
A peptide raised the share reaching a cell collection target to 92.5 percent
In 122 adults with a bone marrow cancer preparing for a transplant of their own stem cells, adding the peptide to the standard injection raised the share who collected enough cells in two sessions from 26.2 percent to 92.5 percent. A later comparison against the drug already in use found no advantage.
9 September 2026 · 6 min read · 3 sources
Trials explained
An antiviral shortened recovery in one trial and did not cut deaths in another
A blinded trial of 1,062 hospital patients found people recovered a median of five days sooner.
9 September 2026 · 6 min read · 4 sources
Trials explained
A review of 19 skin trials found only a small effect on wrinkles
The 19 randomised trials covered 1,341 adults, and the pooled wrinkle figure only just cleared the usual threshold.
8 September 2026 · 6 min read · 4 sources
Trials explained
A higher amount barely changed the weight result in a 76 week trial
A late stage trial split 725 adults between a lower weekly injection, a higher one, and an inactive one.
8 September 2026 · 5 min read · 4 sources
Trials explained
The biggest results for a three receptor drug are still unpublished
One mid stage trial has been through peer review, reporting an average weight reduction of 24.2 percent over 48 weeks.
7 September 2026 · 5 min read · 7 sources
Newsletter
The MetaResearch briefing
A short email when a study worth reading is published, with the finding, its limits and the link to the source.